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Abstract
The Wnt/β-catenin signaling pathway is essential for bone cell viability, function and for skeletal
integrity. To determine if β-catenin in osteocytes plays a role in the bone anabolic response to
mechanical loading, 18-24 wk old osteocyte β-catenin haploinsufficient mice (Dmp1-Cre x β-
catenin fl/+; HET cKO) were compared to their β-catenin fl/fl (control) littermates. Trabecular
BV/TV was significantly less (58.3%) in HET cKO females versus controls, while male HET cKO
and control mice were not significantly different. Trabecular number was significantly less in HET
cKO mice compared to controls for both genders and trabecular separation was greater in female
HET cKO mice. Osteoclast surface was significantly greater in female HET cKO mice. Cortical
bone parameters in males and females showed subtle or no differences between HET cKO and
controls. The right ulnae were loaded in vivo at 100 cycles, 2 Hz, 2500 με, 3 days per week for 3
weeks and the left ulnae served as non-loaded controls. Calcein and alizarin complexone dihydrate
were injected 10 days and 3 days prior to sacrifice, respectively. MicroCT analysis detected an
8.7% and 7.1% increase in cortical thickness in the loaded right ulnae of male and female control
mice, respectively, compared to their non-loaded left ulnae. No significant increase in new cortical
bone formation was observed in the HET cKO mice. Histomorphometric analysis of control mice
showed a significant increase in endocortical and periosteal mineral apposition rate (MAR),
BFR/BS, BFR/BV and BFR/TV in response to loading, but no significant increases were detected
in the loaded HET cKO mice. These data show that deleting a single copy of β-catenin in
osteocytes abolishes the anabolic response to loading and that trabecular bone in females is more
severely affected and suggest that a critical threshold of β-catenin is required for bone formation in
response to mechanical loading.
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Introduction
Bone adapts its mass and architecture in response to mechanical loading, but the exact
cellular mechanisms that mediate this adaptive response are not fully understood. Studies of
human mutations that result in altered bone mass phenotypes first suggested an important
role for the Wnt/β-catenin signaling pathway in bone mass accrual (1–3) and the possible role
of this pathway in bone response to mechanical loading (4). There is now clear evidence that
Wnt/β-catenin signaling is one of the pathways that is activated and involved in bone cells
response to mechanical load (5–15). We have proposed a model in which osteocytes initially
activate β-catenin signaling in response to mechanical loading in part through an Akt
dependent – Lrp5/6 independent mechanism (16). In vitro evidence using osteoblastic and
osteocytic cells supports this model (13,14,17).
The Wnt/β-catenin signaling pathway also regulates basal bone mass through a number of
different mechanisms including renewal of stem cells (18), stimulation of osteoblast
differentiation and proliferation (19), enhancement of osteoblast activity (19,20) and inhibition
of osteoblast and osteocyte apoptosis (21). Conditional deletion of β-catenin in osteoblasts in
vivo using alpha 1 type I collagen Cre (22) or osteocalcin-Cre (23) showed that osteoblast
regulation of osteoclast differentiation was dependent on Wnt/β-catenin signaling. The
mechanism underlying the fragile bone phenotype in these mice is apparently due to
increased osteoclastic bone resorption as a result of decreased expression of
osteoprotegerin(22,23). Interestingly, mice with targeted deletion in osteocytes are born
normal but display progressive bone loss with age accompanied by growth retardation and
premature lethality (24). Cancellous bone mass is almost completely lost and cortical bone
thickness is severely reduced. The low bone mass correlates with increased osteoclast
number and activity due to an increased osteocyte RANKL/OPG ratio (24). Given that the
osteocyte is now recognized as an important source of RANKL (25–27) in bone this raises the
intriguing question of how much of the observed phenotype in the osteoblast targeted
deletions of β-catenin might have been due to osteocyte loss of β-catenin signaling in those
mice (22,23).
The osteocyte is widely believed to be the main mechanosensory cell in bone (16), but there
is limited in vivo evidence demonstrating a clear role for the β-catenin signaling pathway in
osteocytes with regards to anabolic loading induced bone formation. The targeted
homozygous deletion of β-catenin in osteocytes results in a severely fragile skeleton and
these mice do not live much beyond 8 weeks of age (24) making it impossible to perform in
vivo mechanical loading studies with these mice. However, the skeletal phenotype of the
heterozygous mice with the loss of a single β-catenin allele is relatively normal at 2 months
of age with the exception that cancellous bone volume is decreased by about 10% in
heterozygous male and about 25% in heterozygous female mice relative to control
littermates (24).
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Therefore in order to determine whether β-catenin is required for the anabolic bone
formation response to mechanical loading, we conditionally deleted a single allele of β-
catenin in osteocytes (designated HET cKO) by crossing β-catenin fl/fl (designated control)
mice with Dmp1-Cre mice. We report our findings on the characterization of the adult
skeleton and response to anabolic loading of these heterozygous mice and their fl/fl control
littermates at 18-24 weeks of age. Our loading studies demonstrate that deletion of a single
allele of β-catenin in osteocytes abolishes anabolic load-induced new bone formation. Our
studies also revealed major gender differences in trabecular bone phenotypes in HET cKO
mice with a more severe effect of osteocyte β-catenin haploinsufficiency observed in
females.
Methods
Mouse lines and breeding
The β–catenin fl/fl (exon 2–6) mice (control) were purchased originally from Jackson
Laboratories (B6.129-Catnbtm2Kem/J; Jackson Laboratories, Bar Harbor, ME). The β–
catenin fl/fl mice were crossed with the 10Kb Dmp1-Cre mice (28) to produce mice with a
heterozygous deletion of β-catenin in osteocytes. All mice were 18-24 weeks old. The
studies described in this manuscript were approved by the UMKC Institutional Animal Care
and Use Committee.
TRAP Staining
Femurs from male (n=3) and female (n=3) β-catenin fl/fl (control) and HET cKO (male n=3
and female n=5) were excised, cleaned of soft tissue, placed in ice-cold 4%
paraformaldehyde for 24 hours, and decalcified in EDTA for one week. Paraffin-embedded
histological sections were stained for TRAP. TRAP positive osteoclasts were quantified
using the OsteoMeasure Histomorphometry System (Osteometrics Inc., Decatur, GA) in a
standard zone of 1 mm starting 200 μm below the growth plate (to exclude primary
spongiosa) and 100 μm from the cortical bone (to avoid trabecular area associated with
cortical bone). Osteoclast numbers were expressed as N.Oc/BPm and Oc.S/BS according to
accepted histomorphometric standards (29).
High-resolution microcomputed tomography (μCT)
MicroCT analysis of femur/tibia (n=7 for male and female controls and male HET cKO
mice; n=9 for female HET cKO) for baseline characterization and right/left ulnae for loading
studies (n=6 for male and female controls and n=5 for male and female HET cKO) was
conducted using a Scanco vivaCT40 (Scanco Inc., Basel, Switzerland) at a resolution of 10
μm for femurs and tibia and 15 μm for ulna, 55kV voltage, 145 μA current and 200 ms
integration time following recommended guidelines (30). Analysis was performed on post
mortem femurs/tibias that were fixed in 70% ethanol or once embedded in plastic in the case
of the ulnae. Using our standard approach for adult bones, a high resolution scan of the
region of interest was performed. For ulna, the 1 mm between the 2–3 mm distal to midshaft
was analyzed. The threshold used for trabecular and cortical bone was set to 300 and 350
respectively. The region of analysis is shown in figure 1 and comprised 30 slices of
secondary spongiosa beginning just beneath the region of primary spongiosa. Three
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dimensional images were generated using the following values: gauss filter: σ= 0.8; support
= 1; and threshold as noted above. Three dimensional analyses were performed to determine
bone volume/tissue volume, trabecular number, trabecular thickness, and trabecular
separation at the proximal femur and distal tibia. Cortical bone was measured at the mid-
shaft region of the bone. Quantitation of BMD of the bone samples was determined by
comparison against a hydroxyapatite standard (Scanco Inc.) that was scanned weekly for
instrument calibration.
Strain gaging and in vivo loading
For ex vivo strain gaging analysis the gages were applied to the ulnae at 2 mm distal to the
ulna mid-shaft on the medial surface and at a site 5 mm distal to the end of the olecranon
process on the lateral surface. Uniaxial strain gages (EA-06-015DJ-120 -option, Vishay
Micro-Measurements; Raleigh, NC) were glued (Bond 200 kit, Measurements Group) to the
lateral surface and parallel to the longitudinal axis. The forearms (n=3 per gender and
genotype) were placed in the loading system (EnduraTEC ELF 3200 Loading device, BOSE
Corp., Minnetonka, MN) and the device cycled at least 4 times to ascertain that a stable
waveform was obtained before starting data collection. Strain measurements were made
using an electronic bridge conditioner Model 7000-32-SM (Vishay Micro-Measurements;
Raleigh, NC) and digitally displayed using StrainSmart software (Vishay Micro-
Measurements; Raleigh, NC). After application of strain gages, loading was conducted on
the right forearm at 2 Hz, using a haversine waveform for 15 cycles. Loading was conducted
at −0.5, −1, −1.5, −2, −2.5, −3 and −3.5N for the intact forearm. Strains in the last five
cycles were averaged.
In vivo loading was performed on the right ulna of each mouse under compression using the
EnduraTEC ELF 3200 Loading device (BOSE Corp., Minnetonka, MN). Each loading
session was conducted for 100 cycles at 2 Hz. The magnitude of load applied was 2.25N,
sufficient to produce a global strain of 2500 με (10). The left ulnae serve as a contralateral
non-loaded control. Loading was performed three days per week (MWF) for three weeks.
Bone formation analysis
During the 3 week loading regimen, mice were injected with calcein (5 mg/kg) and alizarin
red (20 mg/kg) (Sigma Chemical Company, St. Louis, MO) 10 and 3 days (respectively)
prior to sacrifice and collection of bone samples. The forearms were dissected, fixed in 4%
paraformaldehyde (Alfa Aesar Inc. Ward Hill, MA), methyl methacrylate embedded and
sectioned at a thickness of 20 μm. Sections were taken from the blocks containing bone 3
mm distal to midshaft. Standard bone histomorphometry was performed using the
OsteoMeasure Histomorphometry System. This software follows ASBMR nomenclature for
bone histomorphometry(29). Mineral apposition rate (MAR) and bone formation rate (BFR)
on the endocortical (Ec) and periosteal (Ps) surfaces were calculated from comparable
sections obtained in the midshaft region of the loaded and non-loaded ulnae. BFR was
normalized against either the bone surface (BS), bone volume (BV) or the tissue volume
(TV) as determined by the software per standard convention(29). Periosteal (Ps) and
endocortical (Ec) single label (sL) surfaces (S) were also determined as a function of total
bone surface.
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Ash content
The right and left femurs were processed to determine final mineral content by measurement
of ash fraction (31). Dry mass was obtained by drying in oven at 100°C for 24 hours
followed by 600°C for 24 hours in a muffle furnace. Ash weight was measured and ash
content was expressed as percentage of dry ash mass/dry mass.
Three-point bending to failure
Displacement controlled three-point bending to failure tests were conducted on tibiae and
femurs ex vivo to characterize the biomechanical properties of the bones. Tibiae and femurs
were harvested from freshly sacrificed mice. The associated soft tissue was removed and the
bones were individually wrapped in saline soaked gauze and stored at −20°C until testing.
Prior to biomechanical testing, samples were allowed to thaw and reach room temperature.
Samples were kept hydrated with saline soaked gauze and not allowed to dry out prior to, or
during testing. Span lengths of 7.6 mm were used for the samples and the bones were placed
into the fixture so they would be impacted in what would be the anterior to posterior
direction in vivo. A crosshead displacement rate of 0.1 mm/s was used. Crosshead
displacement and axial load were recorded at a rate of 70 Hz. The stiffness and ultimate
force were calculated from the resulting load verses displacement curves for each bone. The
Young's Modulus (E) for each bone was calculated using the following equation:
where; S is the stiffness, l is the span length, and I is the area moment of inertia. The area
moment of inertia was calculated across the mid-span at the fracture location using ten slices
mid-span of the realigned μCT scans using the BoneJ plug-in for the image processing
program ImageJ (BoneJ, NIH, USA) (32,33).
Statistical Analysis
Two-way ANOVA (analysis of variance) was used to investigate the effect of gender and
treatment. A least square t-test was applied to identify significant differences between
control and HET cKO within the same gender and to test for significance between female
and male within each treatment level. A repeated measurements test was utilized to
investigate the effect of treatment (parameter measured) and loading and gender in which
loading was designated as the within-subject variable with two levels (load and non-load)
and two between-subject variables: gender and treatment. If a significant interaction was
detected, then a simple effect test was applied to identify the significant treatment effect
within same experimental condition. Data analysis was performed with SPSS (Statistical
Package for Social Science, version 20; SPSS Inc., Chicago, IL). A p<0.05 was considered
significant.
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Results
Basal bone properties of HET cKO mice
Homozygous deletion of β-catenin in osteocytes results in a skeleton that is too frail to
withstand in vivo forearm loading (24). We therefore used a heterozygous deletion of β–
catenin strategy in which β-catenin fl/fl mice were crossed with the 10kb Dmp1-Cre mice,
which results in the loss of one allele of β-catenin principally in osteocytes (HET cKO).
These mice are long lived and able to undergo forearm compression loading without
evidence of fracture. MicroCT analysis revealed no significant differences (ns) in femoral
trabecular bone mineral density (BMD) (Figure 1B) or cortical BMD (Figure 1H), although
percentage ash content was lower in the HET cKO mice compared to their gender controls
(p<0.05). 3D images (Figure 1A) show decreased trabecular content in female HET cKO
mice and quantitative analysis demonstrated that femoral trabecular BV/TV was 58.3% less
(p<0.05) in HET cKO females and 19.1% less (not significant, ns) in HET cKO males as
compared to male controls (Figure 1C). Both control and HET cKO females showed lower
BV/TV (p<0.05) compared to their male counterparts (Figure 1C). Significant decreases in
trabecular number were observed in both genders with females significantly lower than their
male counterparts (Figure 1D). Trabecular separation was significantly (p<0.05) increased in
females versus males and in female HET cKO versus female controls (Figure 1F). Female
HET cKO mice also had significantly decreased (p<0.05) trabecular thickness compared to
male HET cKO. Female cortical HET cKO BV/TV was significantly lower compared to
female control mice, but cortical thickness was not different (Figure 1I–1J). Similar findings
were observed in the microCT analysis of the proximal tibia (Supplemental Figure 1).
Histological analysis (Figure 2) revealed a significant increase in the number of TRAP
positive osteoclasts in female HET cKO compared to male HET cKO and to female control
(p<0.05) (Figure 2B). Osteoclast surface per total bone surface in female HET cKO was
significantly higher compared to female control and male HET cKO (p<0.05) (Figure 2C).
Biomechanical properties of osteocyte β–catenin HET cKO mice
We next characterized the biomechanical properties of the femurs and tibiae from these mice
using ex vivo three-point bending to failure. The stiffness, ultimate force, and Young's
modulus were determined. There were no significant differences found between the control
and the HET cKO mice for the femurs and tibiae isolated from either males or females
(Figure 3 and Supplemental Figure 2). We observed a statistically significant increase in the
femoral Young's Modulus (Figure 3) in the female mice compared to their male counterparts
(p<0.05), but no difference in the HET cKO mice of either gender compared to their gender
controls. Tibial mechanical properties showed reduced ultimate load in female mice
compared to their male counterparts.
In vivo bone formation response to loading
Prior to mechanical loading, the strain:load relationship of the ulnae from HET cKO and
control mice was determined using strain gage measurements. As shown in Figure 4 there
were no statistically significant differences in the strain:load curves between males and
females and/or between HET cKO compared to control ulnae. A load of 2.25 N was applied
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to the right forearms of all mice producing a global strain level of ~2500 με. As expected,
there was a significant increase in new bone formation in the control groups in the loaded
compared to the non-loaded ulnae for both males and females on both the periosteal and
endocortical surfaces as shown by double fluorochrome labeling (Figure 5 and 6). However,
the load response observed in the control mice was not observed in the HET cKO group
(both female and male) as evidenced by little or no double labeling (Figure 5 and 6). The
HET cKO mice also had significantly lower amounts of single label surfaces compared to
their controls for both loaded and non-loaded groups of male and female mice (Table 1).
Quantitation of the mineral apposition rates (MAR) and bone formation rate (BFR) using
histomorphometric analysis indicated a statistically significant increase in the MAR and
normalized BFRs, comparing the loaded versus the non-loaded ulnae of the control group
(Figure 6A and 6B and Table 1). In contrast to controls, male and female HET cKO loaded
ulnae MAR and BFRs on both the endocortical and periosteal surfaces were not significantly
different from the non-loaded ulnae (Figure 6A and 6B and Table 1). MicroCT analysis of
loaded and non-loaded ulnae obtained at the end of the 3 week loading regimen also
demonstrated significant increases in control mice cortical thickness (8.7% in males and
7.1% in females) at the midshaft of the ulna corresponding to the region assessed by
dynamic histomorphometry (Figure 6C and Supplemental Figure 3).
Discussion
The Wnt/β-catenin signaling pathway plays an important role in bone mass regulation. In
addition, the osteocytes play an important role in the regulation of osteoblasts and
osteoclasts activity and their role in mechanosensation and responsiveness in bone (16).
Previous work by Kramer et al(24) demonstrated that homozygous deletion of β-catenin
targeted to osteocytes resulted in a severely compromised skeleton by 5–8 weeks of age,
whereas the deletion of a single allele had little or no effect at this young age. Therefore, to
better understand the role of β-catenin in the adult skeleton we examined the basal bone
phenotypes and new bone formation response to anabolic loading in male and female mice,
lacking a single allele of β-catenin in osteocytes.
Characterization of the basal bone phenotype revealed major gender differences as a result
of the targeted deletion of a single allele of β-catenin in osteocytes in trabecular bone of
female compared to male mice, yet no differences in cortical bone. We performed microCT
measurements on 30 slices proximal to the primary spongiosa of the distal femur and
immediately distal to the primary spongiosa of the proximal tibia. Trabecular BV/TV was
significantly reduced in female mice by 58.3% (p<0.05), while trabecular BV/TV in male
mice was decreased 19.1% but was not statistically significant from controls (p=0.745).
However the 3D images suggest that there is less trabecular content in the male HET cKO
towards the femur midshaft, but is still less evident compared to female mice. The data from
Kramer et al., (24) indicated a ~25% reduction in cancellous bone volume in female mice
and a non-significant reduction in male mice at 8 weeks of age. Thus, our data indicates that
the trabecular bone phenotype of the HET cKO mice continues to progressively worsen with
aging. The decrease in trabecular BV/TV appears to be due to increased osteoclast activity
as observed by histological analysis, supporting the concept that β-catenin in osteocytes
regulates osteoclastogenesis (25–27). Given that RANKL expression in the osteocyte is also
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regulated by Wnt/β-catenin signaling (22,23), our findings are consistent with this concept.
Importantly, overall BV/TV was significantly higher in male mice compared to their female
counterparts in both control and HET cKO genotypes.
We did not observe a significant difference in trabecular or cortical bone mineral density
(material density by microCT) in these mice at 18–24 weeks of age compared to controls.
We interpret this as indicating that the bone that is being made has the same material density
in HET cKO mice versus controls, but the reduction in BV/TV indicates there is less bone
present. The decrease in % ash content suggests that there is overall modestly reduced
mineral in the combined cortical and trabecular compartments, which is likely due to
reductions in the trabecular compartments.
Analysis of the biomechanical properties by 3-point bending of control and HET cKO mice
showed no significant differences in male or female mouse femurs and their controls. The
control female group had a significantly higher Young's Modulus compared to male control
mice, which was not evident in the HET cKO group. Perhaps this relates to the greater
decrease in BV/TV in female versus male HET cKO mice. The fact that the biomechanical
properties were not different between male versus female HET cKO is consistent with both
the cortical microCT data and the load:strain curve data, which also showed no differences
between the genders. The deletion of a single allele of β–catenin in osteocytes mainly
appears to affect trabecular bone at 18–24 weeks of age. It will be interesting to determine if
older aged mice (up to 2 years of age) will eventually display cortical effects or if the
changes will remain restricted to trabecular bone.
Our findings of gender differences related to β–catenin signaling has been observed in
previous studies involving other components associated with the pathway, albeit not always
discussed in detail. Yao et al (34) demonstrated that systemic overexpression of sFRP1, a
negative regulator of the Wnt/β–catenin signaling pathway, resulted in an osteopenic
skeleton in which distal femur BV/TV was decreased by 22% in females and 51% in males
and midshaft cortical thickness was 13% lower in females and 21% lower in male mice.
They also reported increased bone resorption in male mice, which appears to be a common
finding in terms of the consequences of altered β–catenin signaling in bone that has been
reported by others (22,23,35). Data from the Sost null mouse (36) demonstrated a more
pronounced BMD increase in the female mice compared to male mice, but was not
discussed, most likely because the data was not specifically analyzed for gender differences.
In a loading study performed with male and female Lrp5 null mice, Sawakami et al (8) noted
greater suppression of load-induced bone formation in female Lrp5 null mice compared to
males. Saxon et al also reported gender related differences in load and disuse studies of Lrp5
null and LRP5 high bone mass (LRP5G171V) mice expressing human LRP5 transgene
containing the G171V activating mutation. The female LRP5G171V mice were more
responsive to lower magnitudes of loads and had less bone loss in response to disuse
compared to males (15). Those authors also puzzled over a possible explanation for their
observed gender differences, but speculated that a possible explanation could be the higher
Lrp5 mRNA expression level compared to controls (21). Javaheri et al. reported gender
related differences in proliferation and apoptosis in primary osteoblast-like cells isolated
from Lrp5 null and LRP5G171V mice compared to cells from wildtype littermates with cells
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isolated from female Lrp5−/− and LRP5G171V mice being more affected by LRP5-β-catenin
signaling (37). Interestingly, the bone biomechanical properties of female and male
LRP5G171V mice did not display gender differences in the study by Akhter et al (5), which
further supports the complex nature of gender influences on β-catenin signaling and the need
for more study. The mechanism underlying this gender difference and the greater sensitivity
of the female skeleton to osteocyte β–catenin haploinsufficiency is not clear. The estrogen
receptor-α has been shown to be important in β–catenin signaling in osteoblasts (11), while
estrogen receptor-β appears to regulate sclerostin production (38). It is reasonable to
speculate that sex hormone differences could underlie this gender difference, but until
studies with gonadectomy are performed in HET cKO mice, the exact mechanism remains
unknown.
The Wnt/β–catenin signaling pathway is activated in response to mechanical
loading (9,10,39). We found that deletion of a single allele of β–catenin in osteocytes has a
profound effect on the anabolic loading response. Ulnae for each group were loaded at a
global load of ~2500 με. Surprisingly the new bone formation observed in response to in
vivo mechanical loading in control mice was essentially absent in the HET cKO mice ulnae.
This was demonstrated by both dynamic histomorphometry of double labeling and by
microCT cortical bone thickness quantitation. These data support the concept that there is a
critical level of β-catenin in osteocytes that is needed to develop a normal skeleton,
adequately contributed by one allele of β-catenin, but the ability to mount a bone formation
response to anabolic mechanical loading requires a higher level of β-catenin expression that
requires both alleles.
Our findings suggest an intriguing, new paradigm for contextualizing bone mass regulation
by the Wnt/β-catenin signaling pathway. Namely, that there is a critical stoichiometry for all
of the key proteins comprising the Wnt/β-catenin signaling pathway that is required for the
proper accrual and maintenance of a normal skeleton. The various mouse and human bone
phenotypes that result from deletions or mutations of components of the Wnt/β-catenin
pathway suggest functional redundancy of its' components (40). As such it is not clear why
deletions or mutations in any of these components produce a bone phenotype. This suggests
to us that the stoichiometry of these various components must be critical. For example, the
LRP5 G171V or HBM transgenic mouse model expresses the human transgene against the
background of two normal mouse alleles producing a high bone mass phenotype, whereas
overexpression of the normal LRP5 transgene only results in a modest increase in bone
mass (21). Deletion of the Sost gene produces a high bone mass phenotype (36), but in a
background in which the expression of other Wnt pathway inhibitors such as Dkk1 are
normal. Similarly the sFRP1 knockout mouse (20) has an increased bone mass phenotype
even though presumably both Sost and Dkk1 expression are normal. Lrp5 homozygous
knockout mice have low bone mass (19), while Lrp6 homozygous knockout mice die at birth
and have multiple patterning defects (41), although studies in Lrp5/Lrp6 mutant mice
indicate that some amount of adult bone mass is also contributed by Lrp6 (42). Lrp4 deficient
mice have a low bone mass phenotype (43), yet both Lrp5 and Lrp6 are still present and
normal. All of these models suggest that there is a critical, yet unknown, balance between
each component of the pathway, and that this nominal equilibrium of all components is
Javaheri et al. Page 9
J Bone Miner Res. Author manuscript; available in PMC 2015 March 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
needed for normal bone growth/mass and accrual. An additional level of complexity that is
not understood is the differential expression at specific stages of development or response of
individual components of this pathway to stimuli, or relative expression in specific cell
types.
Another important consideration is the restricted role of the Wnt/β-catenin signaling
pathway in osteocytes. The osteocyte is considered to be a terminally differentiated cell of
the osteoblast lineage (For review see Dallas et al., 2013 (44)). It resides within the
mineralized matrix and lacks the ability to divide when contained in that environment.
Hence the normal proliferative and differentiation associated functions of the pathway are
not operative in the osteocyte. Proliferation would appear to be a fatal event for the
osteocyte in its lacunae given the space confinement. Therefore, at least two important
functions of β-catenin signaling are abrogated in the case of the osteocyte. It appears that the
pathway in osteocytes is used predominantly as an anti-apoptosis protective mechanism (45)
and in proper response to loading, functions that are observed in many other cells/tissues and
tumors (18,46–54).
In summary, we have demonstrated that mice with a heterozygous deletion of β–catenin in
osteocytes lose the ability to form new bone in response to in vivo mechanical loading. The
effects of osteocyte β–catenin haploinsufficiency are more severe in the female skeleton.
These findings suggest that there is a threshold level of β–catenin in osteocytes that is
required for new bone formation in response to in vivo mechanical loading that is different
than the level required to form the skeleton and that regulation of the pathway is influenced
gender. Our data indicate that a better appreciation of the subtle nuances of regulation of the
Wnt/β-catenin signaling pathway at the level of the stoichiometry and balance of its various
components is required. Secondly, a better understanding of the potential mitigating
influences of gender is needed as new bone anabolic pharmaceutical agents are being
developed that target components of this pathway.
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Figure 1.
Bone phenotype of control and HET cKO femurs. A) Representative 3D μCT images of
femoral trabecular bone. Ex-vivo high-resolution analyses of distal femurs to determine B)
trabecular Bone Mineral Density (BMD), C) trabecular bone volume / total volume
(BV/TV) D) trabecular number, E) trabecular thickness, F) trabecular separation G)
percentage ash content. H) Cortical BMD, I) cortical BV / TV and J) cortical thickness in
control (white bars) and HET cKO mice (gray bars). (B–G) Bar graphs represent means plus
SD. Group size n=7 for male and female controls and male HET cKO mice; n=9 for HET
cKO mice. Statistical comparisons; a: p<0.05 between male and female of same genotype b:
p<0.05 comparing control to HET cKO.
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Figure 2.
Female β–catenin heterozygous deleted mice showed increase osteoclast activity compared
to their controls. A) Shows representative images of fixed sections from femurs. Images
were taken using 40X objective bar = 50μm. B) Histomorphometric quantitation of
osteoclast number per bone perimeter. C) Histomorphometric quantitation of osteoclast
surface per bone perimeter. Group size n=3 for controls, male and female, and male HET
cKO mice. Statistical comparison a: p<0.05 between male and female of same genotype b:
p<0.05 comparing control to HET cKO.
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Figure 3.
Biomechanical properties of control femurs as compared to HET cKO. A) Representative
3D images of entire femur and cortical cross section using the BoneJ plug-in (ImageJ). B)
Table listing the biomechanical parameters: Stiffness, Ultimate Force and Young's Modulus.
Group size n=8 for male controls and HET cKO; n=6 for and female controls; n=10 for
female HET cKO mice. Statistical comparisons; a: p<0.05 between male and female of same
genotype.
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Figure 4.
Strain gage analysis of male (Panel A) and female (Panel B) control and HET cKO ulnae to
determine the load:strain relationship. Group size n=4 for female HET cKO, n=4 for males
HET cKO, female controls n=3 and male controls n=3.
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Figure 5.
β-catenin heterozygous mice have decreased response to loading. Representative images of
double fluorochrome labeling using calcein and alizarin red of loaded and non-loaded ulnae
3 mm distal to the midshaft region. Panel A: Male control and HET cKO mice. Panel B:
Female control and HET cKO mice. Right top corner shows a magnification of similar
regions to better visualize double labeling. Sections were viewed under fluorescent light to
observe mineral deposition due to loading. Control females and males showed clear double
labeling after loading; this response was absent in β-catenin heterozygous mice.
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Figure 6.
Histomorphometric analysis of mineral apposition rates on periosteal and endosteal surfaces
of loaded and non-loaded ulnae. A) endocortical and B) periosteal surface analysis. Group
size was n=5 for males and n=4 for females. C) Representative percent change in cortical
thickness comparing loaded to non-loaded ulnae using μCT analysis. Statistical
comparisons; b: p<0.05 comparing control to HET cKO; c: p<0.05 comparing non-loaded
versus loaded.
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